Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of the project is to investigate exercise performance in humans following bronchodilation induced by acute inhalation of beta2-agonist vilanterol + fluticasone furoate
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Vilanterol + fluticasone furoate | Experimental | Participants are administered Vilanterol + fluticasone furoate from an inhaler device testing |
|
| Placebo | Placebo Comparator | Participants are administered placebo from an inhaler device testing |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Vilanterol and Fluticasone Furoate (low dose) | Drug | Participants are administered 25 µg of vilanterol + fluticasone furoate |
|
| Measure | Description | Time Frame |
|---|---|---|
| Power output during sprint testing | Power output measured in Watts during a sprint on a bike ergometer | Through study completion, an average of 3 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Power output during time trial | Mean power output measured in Watts during a time trial on a bike ergometer | Through study completion, an average of 3 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Forced Expiratory Volume in 1 second (FEV1) | FEV1 measured by spirometry | Through study completion, an average of 3 weeks |
| Quadriceps strength | Maximal torque (Nm) achieved during isometric contraction |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Morten Hostrup, PhD | Contact | +4535321595 | mhostrup@nexs.ku.dk |
| Name | Affiliation | Role |
|---|---|---|
| Morten Hostrup, PhD | University of Copenhagen | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| August Krogh Building | Recruiting | Copenhagen | DK | 2100 | Denmark |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| C550468 | vilanterol |
| C523187 | fluticasone furoate |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Vilanterol and Fluticasone Furoate (high dose) | Drug | Participants are administered 100 µg of vilanterol + fluticasone furoate |
|
| Placebo | Drug | Participants are administered placebo |
|
| Through study completion, an average of 3 weeks |
| Respiratory muscle function | Mouth inspiratory and expiratory pressures against a closed system | Through study completion, an average of 3 weeks |